Evidence map›Paper›PMID 34430312›Full record

ArticleMethodsX2021

Affordable novel device (VY) for transperineal prostate biopsy: A trial on prostate mannequin.

Sawkar Vijay Pramod, Ferry Safriadi, Yasser Kuddah, Richardo Raditya Handoko

Abstract read
In one paragraph

Article in MethodsX, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sawkar Vijay PramodUrology Department, Hasan Sadikin Academic Medical Center, Faculty of Medicine, Universitas Padjajaran Bandung, Jl. Pasteur No. 38 Bandung Jawa Barat, 40161 Indonesia.
Ferry SafriadiUrology Department, Hasan Sadikin Academic Medical Center, Faculty of Medicine, Universitas Padjajaran Bandung, Jl. Pasteur No. 38 Bandung Jawa Barat, 40161 Indonesia.
Yasser KuddahUrology Department, Hasan Sadikin Academic Medical Center, Faculty of Medicine, Universitas Padjajaran Bandung, Jl. Pasteur No. 38 Bandung Jawa Barat, 40161 Indonesia.
Richardo Raditya HandokoUrology Department, Hasan Sadikin Academic Medical Center, Faculty of Medicine, Universitas Padjajaran Bandung, Jl. Pasteur No. 38 Bandung Jawa Barat, 40161 Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is the most frequent malignancy in men worldwide after lung cancer. The gold standard for diagnosing prostate cancer is prostate biopsy. There are two main approaches for diagnosing PCa: transrectal biopsy and transperineal biopsy. In Indonesia, transperineal approach is rarely done as a part of diagnostic work up. The most known method of transperineal biopsy is the fan technique, which is a difficult technique to perform, particularly when directing the needle to the target accurately. For this reason, we develop an affordable bioplastic VY probe mounted needle guide device ($10) to provide precise needle insertion during the biopsy. In this study, we assessed the objective and subjective factors of the newly developed VY device.•Basic knowledge and operation technique were equalized by holding a prostate biopsy training using fan technique and VY device to 20 first-year Residents•Participants were randomized and devided into two groups to perform fan technique and VY technique based on the training given•Subjective factors (usefulness, the easiness, and preference) and objective factors (duration of puncture to needle visualization on USG, biopsy duration time, and the ability to reach the target tissue) were evaluated.

Indexed as

Prostate biopsyTransperineal biopsyVY

Identifiers

PMID34430312
PMCPMC8374447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.